drugset / Press release

New Indication Approved for Yallaferon®

2005-09-07 · Lee's Pharmaceutical Limited · original leespharm.com ↗

Recombinant Human Interferon a-2b · regulatory Recombinant Human Interferon α2b · regulatory Yallaferon® · regulatory

(Hong Kong, 7 September 2005) - Lee's Pharmaceutical Holdings Limited (GEM) Stock: 8221; Website: www.leespharm.com) announced today that Yallaferon® (Recombinant Human Interferon α-2b gel) has been approved for an additional indication for use in the treatment of herpes zoster by the SFDA of China.

The release as fetched from its publisher. leespharm.com ↗